CustomerValidation
- •CellStemCell.2017May4;20(5):621-634.e6.
- •CellStemCell.2016Sep1;19(3):326-40.
- •Endocrinology.2017Nov1;158(11):4064-4075.
- •JOrthopRes.2017Feb;35(2):311-320.
Description | T-5224isaselectiveinhibitorofc-Fos/activatorprotein(AP)-1forrheumatoidarthritistherapy,andinhibitsMMPactivitywithIC50sof10nMforbothMMP-3andMMP-13. |
---|---|
IC50&Target | IC50:10nM(MMP-3),10nM(MMP-13) |
InVitro | T-5224(0-80μM)significantlyinhibitstheinvasion,migration,andMMPactivityofHSC-3-M3cellsinadose-dependentmanner.ThereisnosignificantinfluenceonHSC-3-M3amdOSC-19cellsproliferation[4]. |
InVivo | G2isobservedinratandmonkeylivermicrosomesasamajormetaboliteofT-5224,suggestingthatG2isnotahuman-specificmetabolite[1].T-5224(300mg/kg,p.o.)inhibitstheproductionofTNF-alphaandotherdownstreameffectorsinC57BL/6mice[2].AdmiNISTrationofT-5224(300mg/kg,p.o.)afterintraperitonealinjectionofLPSimpartesappreciableprotectionagainstacuteelevationsinserumlevelsofTNFα,HMGB1,ALT/ASTaswellasinlivertissuelevelsofMIP-1αandMCP-1,andreducesthelethality(27%)[3]. |
References |
|
PreparingStockSolutions |
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent. | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CellAssay [4] | T-5224isdissolvedinDMSOanddilutedinDMEM. HSC-3-M3cellsarestarvedfor24hwithDMEMcontaining0.5%FBS.Thetopchamberofthecellinvasiondeviceiscoatedwith50μLof0.1×basementmembraneextractsolutionandincubataedovernight.HSC-3-M3cells(5.0×104cells/well)areaddedtothetopchamberwithDMEMcontaining0.5%FBSmixedwith0-80μMT-5224;DMEMwith10%FBSisaddedtothebottomchamberandincubatedfor48h.Thebottomplateisreadusingamultilabelplatereader.Thedataarecomparedwiththestandardcurvetodeterminethefractionofinvadedcells.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly. | ||||||||||||||||
AnimalAdministration [2] | T-5224isdissolvedinapolyvinylpyrrolidonesolution,andadjustedtoaconcentrationof30mg/mL. MiceinLPSgroupareadministeredorallywithpolyvinylpyrrolidonesolutioninthesamevolumeofT-5224solutionimmediatelyafterLPSinjection,whileintheT-5224group,miceareadministeredorallywithT-5224(300mg/kg,p.o.)inthesamemanner.Inthecontrolgroup,micereceivespolyvinylpyrrolidonesolutionorallysoonafterintraperitonealsalineinjection.Bloodsamplesarecollectedforeachmeasurementattheoptimaltime.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly. | ||||||||||||||||
References |
|
MolecularWeight | 517.53 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Formula | C₂₉H₂₇NO₈ | ||||||||||||
CASNo. | 530141-72-1 | ||||||||||||
Storage |
| ||||||||||||
Shipping | RoomtemperatureincontinentalUS;mayvaryelsewhere | ||||||||||||
Solvent&Solubility | DMSO:≥31mg/mL T5224isdissolvedinpolyvinylpyrrolidoneK60solution[5]. *"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">1> | ||||||||||||
References |
|
Purity:98.41%